Search filters

List of works by Erica Moretti

Adjuvant chemotherapy: which patient? What regimen?

scientific article published in January 2013

Adjuvant systemic treatment for individual patients with triple negative breast cancer

scientific article published on October 2011

Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream.

scientific article

Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer.

scientific article

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

scientific article published on 05 October 2011

Predicting anthracycline benefit: have we made any progress?

scientific article

Re-searching anthracycline therapy

scientific article published on 15 June 2010

Re: Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.

scientific article

TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer

scientific article

Targeting triple negative breast cancer: is p53 the answer?

scientific article published on 12 January 2013

Taxanes in the elderly: can we gain as much and be less toxic?

scientific article published on 30 August 2008

The continued evidence from overviews: what is the clinical utility?

scientific article published on August 2013

The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.

scientific article published on 15 September 2009

Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.

scientific article published on September 2011